TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NEO

NeoGenomics Inc

Healthcare · Diagnostics & Research

19.30$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

NeoGenomics Inc (NEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,360 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NEO
Line item 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.1 0.4 0.5 0.6 1.1 3.1 6.5 7.3 13 14 20 30 40 81 368 337 343 505 710 988 1,870 1,740 1,681 1,638 1,360
0.0 0.1 0.1 0.1 0.2 0.7 1.9 4.2 4.4 8.5 8.7 13 19 27 59 99 79 85 104 291 449 682 605 597 596 376
0.0 0.1 – 0.0 0.1 0.0 0.1 0.2 0.5 1.6 1.1 2.6 1.9 4.8 34 23 13 13 9.8 173 229 317 263 342 367 160
0.0 0.1 – 0.0 0.1 0.0 0.1 0.2 0.5 1.6 1.1 2.6 1.9 4.8 34 23 13 13 9.8 173 296 515 438 415 387 160
– – 0.0 0.1 0.1 0.6 1.5 3.2 2.9 4.6 5.2 7.9 14 19 20 49 56 60 77 95 107 112 120 131 151 159
– – 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.6 0.9 1.2 1.9 2.3 2.6 5.1 6.3 7.5 8.7 14 30 23 24 24 27 29
– 0.0 0.4 0.4 0.4 0.4 1.2 2.1 2.9 4.3 4.8 6.6 8.6 9.7 15 35 34 37 61 64 86 212 102 – – –
– – – – – – – – – – – 0.0 2.8 2.6 2.9 146 147 147 198 199 211 527 523 523 523 524
– – – – – – – – – – – 0.0 2.8 2.6 4.2 88 77 74 140 127 121 442 408 373 340 287
0.1 0.2 0.4 0.9 1.0 2.1 3.1 4.2 5.8 7.3 11 14 21 18 21 130 151 138 185 202 294 762 742 740 736 523
0.1 0.2 0.4 0.3 1.0 0.7 2.6 3.4 4.4 5.8 9.2 11 18 14 15 40 60 35 61 64 73 87 90 96 301 88
– – 0.0 0.0 0.1 – 1.7 0.2 1.8 2.0 5.4 6.0 11 7.1 3.2 14 31 9.0 20 14 7.8 9.2 6.7 5.6 204 4.8
0.0 0.0 0.1 0.1 0.1 0.5 0.7 1.8 1.5 2.0 1.9 2.5 3.6 4.2 6.3 12 29 10 18 20 25 18 21 20 22 23
– – – 0.6 – – 0.4 0.8 1.4 1.5 1.3 2.6 3.1 3.3 5.3 52 92 91 93 92 168 532 535 538 340 342
-0.1 -0.1 0.0 -0.4 -0.4 -1.0 0.1 2.3 1.5 5.6 3.1 5.9 9.2 22 60 238 187 206 320 507 694 1,108 998 942 902 837
-1.4 -8.1 -8.7 -8.7 -10 -11 -11 -15 -16 -18 -21 -23 -23 -21 -19 -22 -52 -57 -51 -11 -7.2 -15 -159 -247 -326 -434
0.2 0.8 0.9 2.9 4.2 4.5 5.2 6.3 6.3 6.9 7.5 8.6 9.7 11 11 12 78 16 18 21 22 24 25 25 25 26

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?